Work

Improved Patient Satisfaction, Adherence and Health-Related Quality of Life with Deferasirox (Exjade®) in β-Thalassemia Patients Previously Receiving Other Iron Chelation Therapies.

Year: 2009

Type: article

Source: Blood

DOI: 10.1182/blood.v114.22.2486.2486

Authors: John B. Porter, Miranda Athanasiou-Metaxa, Donald K. Bowden, Jacques Troncy, Dany Habr, Gabor Domokos, Bernard Roubert, Diana Rofail, Adam Gater, Jean-François Baladi, M. Domenica Cappellini

Institutions: University College London, Ippokrateio General Hospital of Thessaloniki, Monash Medical Centre, Monash Health, Hôpital Edouard Herriot, Novartis (Switzerland), University of Milan, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

Language: English

Topic: Hemoglobinopathies and Related Disorders

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W119670204

FWCI: 0.302

Cites:

Cited by: 6

Related to: 10